The University of Utah Hospital is a research and teaching hospital on the campus of the University of Utah in Salt Lake City, Utah. It serves as a major regional referral center for Utah and the surrounding states of Idaho, Nevada, Wyoming, Montana and New Mexico.

There are 425 beds in University of Utah Hospital.

During the past decade, University of Utah Hospital conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 58 clinical trials were completed, i.e. on average, 54.7% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 38 clinical trials were completed. i.e. 82.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah Hospital" #1 sponsor was "University of Utah" with 23 trials, followed by "The George Washington University Biostatistics Center" with 17 trials sponsored, "Abbott Medical Devices" with 12 trials sponsored, "Pfizer" with 9 trials sponsored and "BioMarin Pharmaceutical" with 9 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 17 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah Hospital" are "Heart Failure" (9 trials), "Pulmonary Embolism" (7 trials), "Pregnancy" (6 trials), "Duchenne Muscular Dystrophy" (5 trials) and "Acute Respiratory Distress Syndrome" (4 trials). Many other conditions were trialed in "University of Utah Hospital" in a lesser frequency.

Most popular intervention types in "University of Utah Hospital" are "Drug" (92 trials), "Device" (34 trials), "Other" (24 trials), "Biological" (18 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Prednisone" (3 trials), "placebo" (3 trials), "Apixaban" (2 trials) and "Betamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah Hospital" are 135 trials for "All" genders, 31 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 53 active trials in "University of Utah Hospital". 1 are not yet recruiting, 31 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 91 completed trials in University of Utah Hospital, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah Hospital, 14 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 39 trials that are defined as “Not Applicable".